Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Large Drop in Short Interest

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a significant decline in short interest in October. As of October 15th, there was short interest totaling 112,293 shares, a decline of 53.4% from the September 30th total of 240,809 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 667,182 shares, the short-interest ratio is presently 0.2 days.

Azitra Price Performance

Azitra stock traded up $0.01 during mid-day trading on Friday, reaching $0.77. 782,984 shares of the company’s stock were exchanged, compared to its average volume of 8,033,131. Azitra has a twelve month low of $0.52 and a twelve month high of $5.59. The company has a fifty day moving average of $1.90 and a 200-day moving average of $1.96.

Azitra (NYSEAMERICAN:AZTR) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($1.70) EPS for the quarter, missing the consensus estimate of ($1.15) by ($0.55). On average, research analysts expect that Azitra will post -2.00 EPS for the current fiscal year.

About Azitra

Azitra, Inc is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin.

Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment.